Home dialysis therapies for end-stage kidney disease (ESKD), both hemodialysis (HD) and peritoneal dialysis (PD), are underutilized in the United States. The Advancing American Kidney Health (AAKH) Initiative makes clear that initiating and maintaining dialysis patients on home therapies is a national priority. 1 There are several key reasons driving this U.S. policy proceeding. Compared to in-center HD, home dialysis can usually be provided at a lower cost. 2 Home dialysis also allows for more flexible patient-centered schedules, and therefore may contribute to a higher quality of life. 3 Although often debated, evidence suggests that more gradual removal of fluid and solutes is clinically beneficial compared to intermittent removal with the relatively shorter HD treatments provided in outpatient HD units. 4 Recent events due to the COVID-19 pandemic have prompted not only the urgency of home dialysis but its expanded use through widespread authority to provide care through telehealth visits as a mechanism for dialysis patients to safely remain at home. 5 It is not clear that these important changes in delivery of dialysis will continue into the future, and it is only a small component of the necessary strategies to increase access to home dialysis. Several professional societies have met recently, to provide guidance for overcoming operational and policy barriers to home dialysis. 6,7 Sustained, successful home dialysis requires effective and persistent coordination between multiple supportive entities. These include surgeons, home therapy nurses, nephrologists, hospitals, and their staff, and in many cases a caregiver in the home. Advocacy from the local community, and the nephrology community more broadly, is a fundamental requisite to demonstrate to regulatory stakeholders that polices directed at increasing home dialysis access are desired by those who receive and deliver this type of healthcare. Policy is a powerful lever to drive initial action, direct talent, and various resources, and ensure the highest quality of care. The purpose of this review is to provide an overview of where policy, in addition to nephrologist and dialysis center reimbursement, may be needed to support expanded use of home dialysis therapies (Table 1).